S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2022

RTW Investments

Period: Q2 2022 Β· Filed: 2022-08-15
View on SEC EDGAR β†—
AUM
$3.87B
Total portfolio value
Positions
107
Reported securities
Top Holding
ALNY
6.3% $245.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ALNYALNYLAM PHARMACEUTICALS INC$245.5M6.34%$145.85$312.78+114.5%
6.3%
TMOTHERMO FISHER SCIENTIFIC INC$236.6M6.11%$536.82$523.44-2.5%
6.1%
RCKTROCKET PHARMACEUTICALS INC$217.4M5.62%$13.76$3.84-72.1%
5.6%
PTCTPTC THERAPEUTICS INC$202.1M5.22%$40.06$83.31+108.0%
5.2%
MASIMASIMO CORP$176.5M4.56%$130.67β€”
4.6%
ARGXARGENX SE$167.7M4.33%$378.88$939.68+148.0%
4.3%
IMCRIMMUNOCORE HLDGS PLC$149.1M3.85%$37.31$32.50-12.9%
3.9%
ESTAESTABLISHMENT LABS HLDGS INC$128.8M3.33%$54.38$89.25+64.1%
3.3%
MRTXMIRATI THERAPEUTICS INC$126.4M3.27%β€”β€”
3.3%
ILMNILLUMINA INC$104.0M2.69%$179.34$188.68+5.2%
2.7%
CYTKCYTOKINETICS INC$100.6M2.60%$39.29$86.49+120.1%
2.6%
RXDXPROMETHEUS BIOSCIENCES INC$90.0M2.33%β€”β€”
2.3%
VCELVERICEL CORP$88.7M2.29%$25.18$46.98+86.6%
2.3%
PENPENUMBRA INC$87.0M2.25%$124.52$318.57+155.8%
2.3%
CLDXCELLDEX THERAPEUTICS INC NEW$83.2M2.15%$26.96$38.37+42.3%
2.1%
RAREULTRAGENYX PHARMACEUTICAL IN$81.9M2.12%$59.66$33.47-43.9%
2.1%
NTRANATERA INC$75.2M1.94%$35.44$279.32+688.1%
1.9%
RNAMAVIDITY BIOSCIENCES INC$69.7M1.80%β€”β€”
1.8%
AXNXAXONICS INC$66.9M1.73%β€”β€”
1.7%
CUTRQCUTERA INC$66.4M1.72%β€”β€”
1.7%
GMEDGLOBUS MED INC$63.0M1.63%$56.14$80.12+42.7%
1.6%
PMVPPMV PHARMACEUTICALS INC$62.6M1.62%$14.25$1.22-91.4%
1.6%
AXSMAXSOME THERAPEUTICS INC$62.0M1.60%$38.30$244.31+537.9%
1.6%
ACADACADIA PHARMACEUTICALS INC$59.5M1.54%$14.09$25.97+84.3%
1.5%
ACETADICET BIO INC$57.7M1.49%$233.60$9.00-96.2%
1.5%
TNDMTANDEM DIABETES CARE INC$54.6M1.41%$59.19$15.32-74.1%
1.4%
RLMDRELMADA THERAPEUTICS INC$50.1M1.29%$18.99$6.28-66.9%
1.3%
STOKSTOKE THERAPEUTICS INC$48.2M1.25%$13.21$32.70+147.5%
1.3%
RGNXREGENXBIO INC$45.6M1.18%$24.70$13.28-46.2%
1.2%
TXG10X GENOMICS INC$43.4M1.12%$45.25$39.01-13.8%
1.1%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (8)

TickerIssuerNotionalSince Filing
ACADACADIA PHARMACEUTICALS INC$59.5M+84.3%
VERUXXXXVERU INC$25.1M
CYRXCRYOPORT INC$10.4M
ALGNALIGN TECHNOLOGY INC$9.9M
CTKBCYTEK BIOSCIENCES INC$9.8M
CDXSCODEXIS INC$9.6M
SLGCSOMALOGIC INC$9.6M
TWSTTWIST BIOSCIENCE CORP$9.4M

Exited Positions (8)

TickerIssuerNotional
ATHAATHIRA PHARMA INC$25.7M
ITOSITEOS THERAPEUTICS INC$15.7M
NSTGQNANOSTRING TECHNOLOGIES INC$14.0M
PRQRPROQR THRAPEUTICS N V$6.3M
APLSAPELLIS PHARMACEUTICALS INC$2.6M
SOPHSOPHIA GENETICS SA$1.8M
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$1.4M
ADVMADVERUM BIOTECHNOLOGIES INC$0.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
MASS908 DEVICES INC$9.8M+1182.4%
MXCTMAXCYTE INC$2.3M+287.2%
AKYAAKOYA BIOSCIENCES INC$2.1M+200.7%
IMCRIMMUNOCORE HLDGS PLC$93.5M+114.9%-12.9%
CSTLCASTLE BIOSCIENCES INC$-2.2M+84.0%
OLKOLINK HLDG AB$5.8M+53.4%
QTRXQUANTERIX CORP$-7.0M+45.7%
GHGUARDANT HEALTH INC$-8.4M+34.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
PYXSPYXIS ONCOLOGY INC$-6.9M-67.8%
AGENAGENUS INC$-5.7M-55.8%
CTMXCYTOMX THERAPEUTICS INC$-10.2M-50.7%
TBIOCODEX DNA INC$-0.9M-50.0%
GMEDGLOBUS MED INC$-61.2M-33.3%+42.7%
AXNXAXONICS INC$-42.3M-32.3%
CCCCC4 THERAPEUTICS INC$-86.6M-31.7%
LUNGPULMONX CORP$-9.6M-13.4%
← Back to Hedge Funds